ArticleScientific reports2024
Optimization of fermentation conditions for whole cell catalytic synthesis of D-allulose by engineering Escherichia coli.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toxicological Assessment of D-Allulose From a Novel One-Step Fermentation Process Using Genetically ModifiedJournal of toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
D-allulose/D-psicose is a significant rare sugar with broad applications in the pharmaceutical, food, and other industries. In this study, we cloned the D-allulose 3-epimerase (DPEase) gene from Arthrobacter globiformis M30, using pET22b as the vector. The recombinant E. coli strain pET22b(+) was successfully constructed and expressed, providing an efficient whole-cell catalyst for converting inexpensive D-fructose into D-allulose. Subsequently, we optimized the induction and incubation conditions step by step using the single-factor method and used Lactobacillus plantarum(LAB) 217-8 to enhance the purity of D-allulose in the system. Ultimately, the BL21/pET22b(+)-E. coli strain achieved a conversion rate of up to 33.91% under optimal conditions, converting D-fructose to D-allulose. After purification, the purity of D-allulose reached 64.73%. Efficient production of D-allulose is a significant achievement, paving the way for future probiotic applications in its conversion.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.